Novavax Inc (NVAX)

[JoeForkeyBolo]

I've seen a lot of buyout numbers posted on other sites. I believe $50 is too low, although it seems like a good price compared to current share price. However, the new business model for creating great technology and licensing it to BP partners is just getting started. According to CEO Jacobs and other company execs speaking on numerous conference calls or presentations, they plan on licensing the Matrix-M adjuvant to others and stated there is significant interest. That tells me other partnerships are likely forthcoming, similar to the Sanofi deal.

In determining a fair buyout price that would be accepted, they would need to factor in not only the expected revenues from the Sanofi partnership, but the revenues other partners might bring over the next 5-10 years, adjusted for current valuation. My gut tells me that is far above $50/share and $100+ is more likely. While many shareholders might be willing to accept a $50 offer, I don't think the company would settle for such a low value with the revenue the new business model and the company IP would be expected to bring in the coming years.

My hope for Novavax is they partner with several BP's and when the time comes for a buyout offer, a bidding war ensues. 😎